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18 F-fluorodeoxyglucose positron emission
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literature
Rosa Nguyen1*, Jamie L Coleman2, Scott C Howard3,4 and Monika L Metzger3,4Abstract
Background: Benign hyperplastic thymus is a rare but important differential diagnosis of anterior mediastinal
lesions. Histological and radiological criteria are used to distinguish this benign condition from other malignant
diseases but have their limitations, and biopsy of mediastinal masses can be risky. We report for the first time the
diagnostic value of fluorodeoxyglucose 18 F positron emission tomography for patients with incidentally identified
anterior mediastinal masses to avoid biopsy in some cases.
Case presentation: A 2 year old girl presented with new onset of emesis and constipation leading to the
incidental discovery of an anterior mediastinal mass on radiograph. Chest computed tomography revealed cystic
components within the mass concerning for a malignancy. Biopsy of the lesion and bone marrow aspiration and
biopsy were negative but there was concern that the mediastinal biopsy may have missed the malignant
component of the lesion. Hence, a positron emission tomography scan was obtained that showed mild
homogeneous fluorodeoxyglucose 18 F avidity within the mass similar to that of normal thymus. The diagnosis of
benign hyperplastic thymus was made.
Conclusion: The differential diagnosis of an incidentally found anterior mediastinal mass includes malignancy, but
benign lesions such as benign hyperplastic thymus must also be considered, particularly when the complete blood
count and biochemical profile are normal. Fluorodeoxyglucose 18 F positron emission tomography can help guide a
clinician’s decision for further interventions and treatment.
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Potential etiologies of anterior mediastinal masses in
children include benign and malignant tumors whose
incidences vary by patient age and symptoms at pres-
entation. Benign hyperplastic thymus (BHT) is a rare
condition that occurs mainly in infants and usually
resolves spontaneously by 3 years of age, while it sel-
dom occurs in older children and never in adults* Correspondence: rosi.nguyen@gmail.com
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reproduction in any medium, provided the or[1-3]. BHT is characterized by an increase in size of the
thymus with normal histological architecture [1-5]. Hence,
BHT must be distinguished from follicular hyperplasia in
association with Graves’ disease, rebound thymus hyper-
plasia in cancer patients after chemotherapy, or thymoma
and thymolipoma, which do not meet histological criteria
for BHT and are mainly seen in adolescents and adults,
respectively [1,6,7].
Diagnoses such as germ cell tumor, thyroid cancer,
and lymphomas (Hodgkin and non-Hodgkin) must be
ruled out during diagnostic workup. BHT spontaneously
resolves over time, without specific treatment orl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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from that of malignant etiologies [1,8]. Fine-needle
aspiration cytology and imaging studies (e.g., chest
radiograph, ultrasound, and computed tomography
[CT]) are used to diagnose BHT in a minimally invasive
manner but may result in inadequate biopsy specimens
or inconclusive radiologic findings, requiring more in-
vasive and potentially dangerous procedures [9-11]. In
one study of 54 children and adults who underwent
mediastinal biopsy, the procedure-related morbidity
was 6%, and fatalities have been reported [12].
Here we describe a child whose diagnosis of BHT was
based on CT-guided core needle biopsy and supported
by conventional imaging and 18 F-fluorodeoxyglucose
(FDG) positron emission tomography (PET) scan. PET
can help differentiate BHT from other conditions associ-
ated with an anterior mediastinal mass.
Case presentation
A 2-year-old girl with no significant past medical his-
tory was in her usual state of health when she devel-
oped non-bloody and non-bilious emesis associatedFigure 1 Diagnostic imaging studies of the presented patient. (A) Ant
right-sided mass. (B) PET image shows that activity within the mass (b
(white arrow). (C) Fused transaxial 18 F-FDG PET/CT shows only low-inte
photopenia corresponding to the cystic/necrotic area (white arrow).with constipation. A review of other systems was negative.
She did not take any medications and family history
was non-contributory. In the emergency room, she
appeared well and in no acute distress, with a normal
physical examination. Weight, height, and vital signs
were normal for age and gender. A chest/abdominal
radiograph to evaluate her constipation showed no
intra-abdominal pathology but demonstrated medias-
tinal widening (Figure 1A). A CT scan revealed a
10.3 cm × 6.6 cm × 6.3 cm heterogeneous, right-
sided anterior mediastinal mass with a single hypodense
area likely representing necrosis, and compression of
bronchovascular structures. Laboratory tests showed
no hematologic or metabolic derangements.
The patient underwent CT-guided core needle bi-
opsy of the lesion, bilateral bone marrow aspirates
and biopsies to rule out a malignancy. Hematoxylin
and eosin staining and immunohistochemical studies
of the mediastinal mass biopsy showed preservation
of thymic architecture, with sheets of variably mature
small- to intermediate-sized lymphoid cells and few
Hassall's corpuscles, consistent with benign thymiceroposterior chest radiograph reveals a large predominately
lack arrow) is indistinguishable from that in the normal thymus
nsity, homogeneous 18 F-FDG avidity within the mass, with
Table 1 Differential diagnosis of mediastinal masses in children
Differential
diagnosis
Diagnostic imaging modality Comments
Computed tomography Magnetic resonance PET scan
Normal thymus Quadrilateral with convex or straight margins in infants,
triangular with concave or straight margins in older
children
Bilobed, convex at birth, straight during puberty, concave
in old age, greater generalized T1-weighted and fast spin-
echo T2-weighted hyperintensity and diminishing
intermediate T1- and















Symmetrically enlarged, normal sized in 25%-50% Enlarged, thymus characteristics similar to normal thymus
(see above)











Thymolipoma Pericardial fatty mass with fibrous septa Hyperintense T1-signal resembling subcutaneous fat and
area with intermediate intensity soft of tissue attenuation
Resembling uptake in





Lymphoma Homogeneous or heterogeneous, nodular, hemorrhage,
necrosis, cystic components
Homogeneous low-signal on T1-weighted images, high-






Teratoma Well-circumscribed, displacing mass, calcification (80%),
fat-fluid levels, cystic, heterogeneous changes in lung
parenchyma, pleura, or pericardium (tumor rupture)
Hyperintense fat on T1-weighted images within fluid of
low signal intensity (cystic changes), hyperintense mass on
T2-weighted images
Heterogeneously avid Tissue from germ-cell
layers
Seminoma Large and lobular, homogenous High-intensity mass with with septal structures in T2-
weighted images
Heterogeneously avid Most common primary





Large, lobulated, heterogeneous masses with large
(>50%) areas of low attenuation, hemorrhage, necrosis
Internal heterogeneous intensities with areas of high signal
intensity reflecting degenerative cystic changes on T2-
weighted images.
Heterogeneously avid Highly aggressive
Thyroid
carcinoma
Well-defined, smooth or lobuated, tracheal deviation,
contrast-enhancing, calcifications
Most tumors are hyperintense of markedly hyperintense on
T2-weighted images


















Table 2 Reported cases of benign thymic hyperplasia





Oh [17] 1 F 15 15 × 10 × 2 cm, 102 g Pulmonary infection Fluoroscopy,
angiography
Histology Open resection None
2 F 14 8.4 × 2.8 × 1.4 cm, 20 g Upper respiratory
infection
Fluoroscopy Histology Open resection None
Ruco [5] - M 5 950 g Dyspnea None Histology Open resection None
O'Shea [18] - M 1 420 g Dyspnea, lymphocytosis CXR FNA, histology Steroids, open resection 5 months
Barcia [19] 2 M 4 47-92 g Pulmonary infection CXR Histology Open resection 1 month
3 M 1 47-92 g Pulmonary infection CXR Histology Open resection 1 month
11 F 9 47-92 g Chest discomfort CXR Histology Steroids, open resection 1.5 years
Rasore-Quintino [20] - M 4 800 g Pulmonary infection 99Technetium
scan
Histology Open resection None
Lack [6] 2 M 11 15.2 cm, 324 g Mild dyspnea, URI CXR Histology Open resection 9 years
Lamesch
AJ [21]
- M 6/12 230 g Respiratory distress CXR Histology Ventilation, steroids,
open resection
6 years
Parker [11] - M 1 3/12 200 g Pulmonary infection CXR, US,
fluoroscopy, CT
Histology Open resection None
Kobayashi [22] 1 M 1/12 - Respiratory distress,
lymphocytosis
CXR, CT None Observation, steroids Intensive care unit
admission, no follow-up
2 M 2/12 - Respiratory distress,
lymphocytosis
CXR, CT None Observation, steroids None
3 M 4/12 - Pulmonary infection,
lymphocytosis
CXR, CT None Observation, steroids None
4 F 1/12 - Respiratory distress,
lymphocytosis
CXR, CT None Observation None
Nezelof [23] 1 F 10 93 g Cough CXR Histology Open resection None/uneventful
follow up
Judd [24] - M 12 13 × 8 × 3.5 cm, 245 g Wheezing, dysphagia CXR Basic laboratory
tests, histology
Open resection None
Ricci [2] 3 M 14 850 g Dyspnea, altered LFTs,
atelectasis
CXR, CT ECG, LFTs,
histology
Open resection 9 years
4 M 5 950 g Dyspnea CXR, CT ECG, EMG, LFTs,
biopsy ×2, histology
Open partial resection Wound infection,
osteomyelitis, lung
atelectasis/1 month
Linegar [8] 1 F 2/12 220 g URI, lymphocytosis,
splenomegaly


















Table 2 Reported cases of benign thymic hyperplasia (Continued)
2 M 3 18 × 10 × 6 cm, 855 g Recurrent URI,
lymphocytosis
CXR Histology Open resection None
3 M 6 1260 g Wheezing, dyspnea,
respiratory distress
CXR, CT FNA, histology N/A None
4 M 3 100 g Recurrent URI CXR Histology Open resection None





2 M 11/12 500 g URI, lymphocytosis,
mediastinal shift
CT Histology Open resection None




Steroids Death 10 months after
diagnosis of unknown
cause/8 months
Hoerl [10] - M 5/12 4.6 cm AP Choking CT FNA, histology Observation 1 year
Tareen [26] 1 M 3/12 - Persisting URI CT, CXR, US None Steroids, observation 6 months
2 M 8/12 - Recurrent URI, dyspnea,
tachypnea
CXR, CT FNA, histology Open resection 6 months
Sosothikul [27] - M 4 - Dyspnea, wheeze CXR, CT BMA, histology Observation Involution/1 month




Open resection 1 year
Piednoir [29] - M 3/12 - Anesthesia related
respiratory distress,
incidental finding
CT None Observation Involution/2 years
Szarf [30] - M 2 830 g Fever, dry cough and
dyspnea
CXR, CT Alpha-FP, beta-HCG,
FNA, histology
Steroids, open resection Reoccurrence of
symptoms
Tan [31] - F 9/12 17.5 × 11 × 5 Upper respiratory
infection
CXR, MRI FNA, histology Steroids, open resection None
Asymptomatic cases
Oh [17] 3 F 10 80 g Incidental finding Fluoroscopy Basic laboratory
tests, histology
Open resection None
Katz [32] - M 7/12 9 × 8 × 6 cm, 224 g Incidental finding,
lymphocytosis







Barcia [19] 1 M 4 47-92 g Incidental finding CXR Histology Open resection 1 year
5 F 11 47-92 g Incidental finding CXR Histology Steroids, open resection 3 months
6 F 3 47-92 g Incidental finding CXR Histology Open resection 3 months
7 M 4 47-92 g Incidental finding CXR Histology Open resection 1 year
8 M 4 47-92 g Incidental finding CXR Histology Open resection 2 years


















Table 2 Reported cases of benign thymic hyperplasia (Continued)
10 M 13 47-92 g Incidental finding CXR Histology Open resection 4 months
Lee [33] - F 2 19 × 12 × 4.5 cm Incidental finding CXR Histology Oral steroids, open resection None
Lack [6] 1 M 14 490 g Incidental finding,
lymphocytosis
CXR Histology Open resection 17 years







3 F 11 N/A Incidental finding CXR,
mediastinoscopy
Biopsy, histology Observation None
Arliss [34] - M 15 17 × 16 × 6 cm, 680 g Incidental finding,
lymphocytosis
CXR, CT Histology Open resection 1 4/12 years
Ricci [2] 1 M 16 13 cm,250 g Incidental finding CXR, CT ECG, EMG, LFTs,
histology
Open resection 12 years
2 M 12 7.5 cm,120 g Incidental finding CXR, CT ECG, EMG, LFTs,
histology
Open resection 7 years
Rice [3] - M 10 482 g Incidental finding MRI BMA, histology Open resection None











Current case - F 2 Incidental finding CRX, CT, PET Core needle biopsy Observation
* If number of patients with benign thymus hyperplasia and patients with other conditions is provided in report.
CT Computed tomography, CXR Chest radiograph, ECG Electrocardiogram, EMG Electromyogram, FNA Fine needle aspiration, LFTs Liver function tests, MRI Magnetic resonance imaging, N/A Not applicable, PET Positron
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full spectrum of orderly thymic maturation patterns, and
bone marrow aspirates and biopsies showed normocellular
marrow (80%) with trilineage hematopoiesis without
evidence of leukemia or lymphoma.
However, the inhomogeneous area within the mass
on CT imaging is not a typical finding of BHT and
raised concern for a malignancy such as teratoma or
lymphoma, which may present with such features
(Table 1). PET-CT scan of the large anterior medias-
tinal mass showedareas of low-intensity, and diffuse,
homogeneous FDG avidity, similar to the normal thy-
mus (Figure 1B). Central low-attenuation areas by CT
within the mass lacked FDG activity and are suggest-
ive of necrosis (Figure 1C). The standardized uptake
value of the lesions ranged from 2.3 to 2.5 MBq/kg,Figure 2 Flow chart for the workup of a mediastinal mass in an otherexcept for the cystic area, which had values less than
2 MBq/kg.
The diagnosis of BHT was made based on histology
and lack of FDG avidity on PET scan. The patient con-
tinues routine follow up almost a year after original
diagnosis with stable mediastinal mass and no further
problems or complaints.
Discussion
As the scope of diagnostic imaging broadens, there is
greater likelihood of incidental detection of anterior
mediastinal masses. Lymphomas and germ cell tumors
are the most common malignant tumors of the anterior
mediastinum in children; whereas, thymomas seldom
occur in this age group [13]. Thymolipomas may occur
in young adolescents and adults and occasionallywise asymptomatic child.
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resemble BHT, thymolipomas present on MRI as mainly
fatty masses with inhomogeneous areas that represent
thymus tissue [14,15]. BHT is a rare but important
benign condition and must be differentiated from malig-
nant and other benign tumors.
To date, 53 patients with BHT have been reported
(Table 2); 34 (64%) of them had respiratory symptoms,
and imaging studies revealed a mediastinal mass. In
the remaining 19 (36%) patients, the mediastinal le-
sion was an incidental finding. In either scenario, fur-
ther diagnostic workup was warranted to rule out a
malignancy; however, the implication of malignancy
together with imaging findings and parental fear may
have led to use of invasive interventions for diagnos-
tic confirmation. Indeed, 79% (15/19) of asymptomatic
patients underwent open biopsy and only 26% (9/34)
of symptomatic patients were observed clinically with-
out biopsy. In symptomatic patients, open biopsy can
be diagnostic and therapeutic, but less invasive proce-
dures are preferred [16].
The primary goal while assessing a mediastinal mass is
to rule out oncologic emergencies (anatomic, metabolic,
or hematologic) that require immediate medical at-
tention. Workup includes patient’s history, physical
examination, routine laboratory tests, and anatomic
imaging (Figure 2). After excluding oncologic emer-
gencies, further tests are needed to diagnose the me-
diastinal lesion.
Physiologic imaging, most often PET-CT, is
recommended in the diagnostic process when uncer-
tainty about the malignant versus benign nature of
the mass persists (Figure 2) [35].
The pattern and intensity of uptake within such le-
sions on PET and morphologic appearance on CT can
help differentiate benign from malignant etiologies
[36] (also see Table 1). To accurately interpret BHT
in PET studies, FDG uptake patterns in the normal
thymus and pathologic entities involving the thymus
need to be known [37]. Normal thymic tissue and be-
nign conditions such as BHT after chemotherapy (so
called “thymic rebound”), comparable to our patient,
demonstrate diffuse, low-intensity, homogeneous FDG
avidity (Table 1) [38,39].
Malignant conditions show intense FDG avidity that is
usually heterogeneous in distribution [40]. The appear-
ance of our patient’s lesion was similar to the normal
thymus without focality, suggesting its benign nature
(Figure 1B), [41] despite the cystic and necrotic areas
within the mass [36,42]. The morphology and uptake
pattern on 18 F-FDG PET are more meaningful than the
SUV. There is an overlap in SUV range between normal
thymus and other malignant anterior mediastinal tumor
entities [43]. Although a very high SUV may beindicative of malignancy, an average SUV does not ex-
clude malignancy [36,43].
Conclusion
In conclusion, for incidentally found anterior medias-
tinal masses in otherwise healthy children, we recom-
mend that clinicians expeditiously rule out oncologic
emergencies then perform a diagnostic workup. PET
scans can help differentiate BHT from other more serious
conditions and may spare patients invasive diagnostic
procedures.
Further studies including large pediatric series are needed
to evaluate the importance of 18 F-fluorodeoxyglucose
positron emission tomography in patients with suspected
benign hyperplastic thymus.
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